Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Claire Fraser, insider at Becton, Dickinson and
Claire Fraser Insider Alerts

Get notified the next time Claire Fraser buys or sells Becton, Dickinson and stock. Enter your email address below to get our daily insider buying and selling report.

Claire Fraser Insider Information

Claire M. Fraser, Ph.D., serves as a director of BD (Becton, Dickinson and Company), a global medical technology company headquartered in Franklin Lakes, New Jersey. Dr. Fraser has been a member of the board since 2016.

Dr. Fraser is the director of the Institute for Genome Sciences and a Professor of Medicine and Microbiology and Immunology at the University of Maryland School of Medicine in Baltimore, Maryland. From 1998 to 2007, she served as president and director of The Institute for Genomic Research, a not-for-profit research organization engaged in human and microbial genomics studies. Dr. Fraser is the president and a director of the American Association for the Advancement of Science and also serves as a director of Ohana Biosciences Inc.

Dr. Fraser is a prominent scientist with a strong background in infectious diseases and molecular diagnostics, including the development of novel diagnostics and vaccines. She also brings considerable managerial experience in her field.

How do I contact Claire Fraser?

The corporate mailing address for Dr. Fraser and other Becton, Dickinson and executives is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. Becton, Dickinson and can also be reached via phone at (201) 847-6800.

Has Claire Fraser been buying or selling shares of Becton, Dickinson and?

Claire Fraser has not been actively trading shares of Becton, Dickinson and during the past quarter. Most recently, Claire Fraser sold 387 shares of the business's stock in a transaction on Wednesday, August 18th. The shares were sold at an average price of $251.58, for a transaction totalling $97,361.46.

Who are Becton, Dickinson and's active insiders?

Becton, Dickinson and's insider roster includes Claire Fraser (Director), James Lim (EVP), Rebecca Rimel (Director), and Thomas Spoerel (VP).

Are insiders buying or selling shares of Becton, Dickinson and?

During the last year, insiders at the medical instruments supplier sold shares 10 times. They sold a total of 12,912 shares worth more than $3,253,428.82. The most recent insider tranaction occured on September, 8th when Director Rebecca W. Rimel sold 500 shares worth more than $130,000.00. Insiders at Becton, Dickinson and own 0.8 % of the company.

Information on this page was last updated on 9/8/2021.

Claire Fraser Insider Trading History at Becton, Dickinson and

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/18/2021Sell387$251.58$97,361.46View SEC Filing Icon  
5/27/2021Sell390$241.36$94,130.40View SEC Filing Icon  
2/11/2020Sell1,500$258.72$388,080.00View SEC Filing Icon  
8/7/2019Sell1,429$243.26$347,618.54View SEC Filing Icon  
See Full Table

Claire Fraser Buying and Selling Activity at Becton, Dickinson and

This chart shows Claire Fraser's buying and selling at Becton, Dickinson and by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Becton, Dickinson and Company Overview

Becton, Dickinson and logo
Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens; and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Read More

Today's Range

Now: $244.12
Low: $240.56
High: $244.25

50 Day Range

MA: $244.06
Low: $235.83
High: $251.79

2 Week Range

Now: $244.12
Low: $234.61
High: $267.37

Volume

1,275,915 shs

Average Volume

1,509,985 shs

Market Capitalization

$69.33 billion

P/E Ratio

35.64

Dividend Yield

1.37%

Beta

0.71
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!